Main Article Content
Background: The unprecedented outbreak of 2019 novel coronavirus disease (COVID-19) drastically spread worldwide. The study was aimed to articulate the findings of a descriptive and clinical characteristic, also to access the potential risk factors link with the spread of COVID-19. Method: The COVID-19 cases reported through April 30, 2020, were extracted from Balochistan’s COVID-19 Electronic Dashboard. All cases from March to April 2020 were included. The results of the laboratory finding as well as data acquired through COVID-19 Dashboard were cleaned; descriptive exploratory analysis and chi-square were calculated to demonstrate association using Epi- Info. Results: A total of 1381 patient records extracted and screened. Of these, 1218 suspected cases and 1049 confirmed cases contributed to the analysis. Among confirmed cases, 77% (811) were male. The most affected age group was 60 – 69 years (attack rate 1.90/10,000), mean age was 36 ±17.11 SD with age range 2 months-94 years. District Quetta 82% (864) and district Pishin 5% (55) remained the epicenter for high attack rates. Among confirmed cases, a total of 14 deaths occurred for an overall Case fatality rate of 1.33%. The epi surge was peaked around March 19, April 5, and April 24, 2020. Among high-risk personals, those who had contact with infected individuals’ showed a high association of 97% (323/333) than without any contact 87% (221/254). Those who had travel history showed a prevalence of 86% (87/101) than in those who did not 59% (60/104) while those admitted in hospital with comorbid conditions showed a prevalence of 70% (26/37) than in those who did not 13% (6/46). Conclusion: COVID-19 epidemic has spread rapidly in the province. A series of multidimensional public health interventions, a cost-effective surveillance system, and the adoption of safe working practice, awareness sessions are necessary to control the COVID-19 outbreak.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Journal of Basic and Applied Research in Biomedicine by authors is licensed under a Creative Commons Attribution 4.0 International License.
Alhogbani, T. (2016). Acute myocarditis associated with novel Middle East respiratory syndrome coronavirus. Annals of Saudi medicine, 36(1), 78-80
Bastola, A., Sah, R., Rodriguez-Morales, A. J., Lal, B. K., Jha, R., Ojha, H. C., & Morita, K. (2020). The first 2019 novel coronavirus case in Nepal. The Lancet Infectious Diseases, 20(3), 279-280.
Bogoch, I. I., Watts, A., Thomas-Bachli, A., Huber, C., Kraemer, M. U., & Khan, K. (2020). Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel. Journal of travel medicine, 27(2), taaa008.
Bassetti, M., Vena, A., & Giacobbe, D. R. (2020). The novel Chinese coronavirus (2019?nCoV) infections: Challenges for fighting the storm. European journal of clinical investigation, 50(3), e13209.
Badshah, S. L., Ullah, A., Badshah, S. H., & Ahmad, I. (2020). Spread of Novel coronavirus by returning pilgrims from Iran to Pakistan. Journal of Travel Medicine, 27(3), taaa044.
Carlos, W. G., Dela Cruz, C. S., Cao, B., Pasnick, S., & Jamil, S. (2020). COVID-19 Disease due to SARS-CoV-2 (Novel Coronavirus). American Journal of Respiratory and Critical Care Medicine, 201(4), 7-P8.
Coronavirus Outbreak. Available at: https://www.worldometers. info/coronavirus/. Accessed 23 July 2020.
Government of Pakistan (2020) COVID-19 Health Advisory Platform by Ministry of National Health Services Regulations and Coordination http://covid.gov.pk/stats/global Accessed 23 July 2020.
Government of Pakistan, Ministry of Health services, Regulations and Coordination (2020) National Action Plan for Preparedness & Response to Corona Virus Disease (COVID-19) Pakistan. https//www.nih.org.pk/wp-content/uploads/2020/02/NAP-covid-19_AL@version-3-date-12-2-2020-with-annexures.pdf Accessed 23 July 2020.
Herald Med. (2020) Medical expert group of Tongji hospital. Quick guide to the diagnosis and treatment of pneumonia for novel coronavirus infections (third edition). Accessed 23 July 2020
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., & Cheng, Z. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 395(10223), 497-506.
Lee, A. (2020). Wuhan novel coronavirus (COVID-19): why global control is challenging. Public health, 179, A1.
Li, T., Wei, C., Li, W., Hongwei, F., & Shi, J. (2020). Beijing Union Medical College Hospital on" pneumonia of novel coronavirus infection" diagnosis and treatment proposal (V2. 0). Med J Peking Union Med Coll Hosp. http://kns.cnki.net/kcms/detail/11.5882.r.20200130.1430.002.html. Accessed 23 July 2020.
Lu, H., Stratton, C. W., & Tang, Y. W. (2020). Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. Journal of medical virology, 92(4), 401-402.
Millán-Oñate, J., Rodriguez-Morales, A. J., Camacho-Moreno, G., Mendoza-Ramírez, H., Rodríguez-Sabogal, I. A., & Álvarez-Moreno, C. (2020). A new emerging zoonotic virus of concern: the 2019 novel Coronavirus (SARS CoV-2). Infectio, 24(3), 187-192.
Noreen, N., Siddiqui, SW., Niazi SUK., Khudaidad F, Khudaidad., NU, Khan., Dil S., Khan, MA., & Naveed, I. (2020). COVID-19 Outbreak in Pakistan; a Situational Analysis. Journal of Emerging Diseases and Virology. 5. 10.16966/2473-1846.153.
Noreen, N., Dil, S., Niazi, S. U. K., Naveed, I., Khan, N. U., Khan, F. K., Kumar, D. (2020). COVID 19 Pandemic & Pakistan; Limitations and Gaps. Global Biosecurity, 1(4).
Novel, C. P. E. R. E. (2020). The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua liu xing bing xue za zhi= Zhonghua liuxingbingxue zazhi, 41(2), 145-151.
Petersen HE, Baloch SM (2020) Pakistan coronavirus cam: ‘No facilities, no humanity.’
Selvey, L. A., Antão, C., & Hall, R. (2015). Evaluation of border entry screening for infectious diseases in humans. Emerging infectious diseases, 21(2), 197.
Shen, K., Yang, Y., Wang, T., Zhao, D., Jiang, Y., Jin, R., & Shang, Y. (2020). Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement. World journal of pediatrics 16, 223-231.
WHO Corovirus Disease Dashboard https://covid19.who.int/ Accessed 23 July 2020
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., & Zhao, Y. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama, 323(11), 1061-1069.
Yang, X., Yu, Y., Xu, J., Shu, H., Liu, H., Wu, Y., ... & Wang, Y. (2020). Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine 8(5), 475-481
Zheng, Y. Y., Ma, Y. T., Zhang, J. Y., & Xie, X. (2020). COVID-19 and the cardiovascular system. Nature Reviews Cardiology, 17(5), 259-260.
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J.,& Niu, P. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine 282(8), 1-7